Cambridge Innovation Capital — Full Portfolio

BiotechCambridge

Jeffrey Buchalter(Director)Clive Morris(Executive Officer, Director)Peter Wright-Smith(Director)Douglas M. VanOrt(Director)Timothy Shannon(Executive Officer)

Board seatRobert Tansley· per SEC Form D

Co-investorsAlbionVC

Co-investorsMartlet CapitalWalking Ventures

BeyondMath builds a foundational AI model trained on the laws of physics to run full-fidelity simulations and validate engineering designs at high speed with engineering-grade accuracy.

AI & Machine LearningDeep TechEnterprise Software

Co-investorsUP Partners

Bicycle Therapeutics develops precision-guided therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, designed to penetrate deep into tissues and target intractable solid tumor cancers.

BiotechHealthtechCambridge

KEVIN LEE(Executive Officer, Director)FELIX J. BAKER(Director)RICHARD N. KENDER(Director)GREGORY WINTER(Director)STEPHEN SANDS(Director)NIGEL CROCKETT(Executive Officer)

Co-investorsAhren Innovation CapitalAstellas Venture Management LLCLongwood FundSR One Capital ManagementSV Health InvestorsVertex Ventures HC

Cambridge GaN Devices (CGD) designs ICeGaN gallium nitride power transistors that integrate temperature control and gate reliability features and can be driven by standard silicon gate drivers.

Deep TechHardwareSemiconductors

Fabio Necco(CEO)

Co-investorsEMV CapitalIQ CapitalMartlet CapitalBritish Patient Capital

Carrick Therapeutics is a biopharmaceutical company with a leadership team experienced in oncology drug development and commercialization.

BiotechDigital HealthHealthtechMedical Devices

Timothy Pearson(CEO)Ash Bahl(CSO)Jenny Horsfield(CBO)Stuart McIntosh(CMO)David Sutherland(VP Finance & Controller)

Co-investorsARCH Venture PartnersB Capital GroupB4 CapitalLightstone Ventures

Centessa is a biopharmaceutical company developing an Orexin Receptor 2 Agonist program aimed at treating sleep-wake, neurological, neurodegenerative, and neuropsychiatric disorders.

BiotechHealthtech

Co-investorsAdvent Life SciencesEcoR1 CapitalForesite CapitalMedicxiOberland CapitalScion Life Sciences+1 more

CMR Surgical develops Versius, a small, modular, and portable surgical robot that enables hospitals and surgeons to perform minimal access (keyhole) surgery.

HealthtechMedical DevicesRobotics

Massimillano Colella(Chief Executive Officer)

Co-investorsLightrockSandwaterSoftBank Vision FundWatrium

Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.

BiotechDigital HealthHealthtechMedical DevicesMunich, DE

Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in

Co-investorsHadean VenturesSeroba Life SciencesBioGeneration Ventures

Congenica offers an AI-powered next-generation sequencing platform that turns raw genomic sequencing data into clinical insights across rare disease, oncology, and infectious diseases, along with clinical interpretation services staffed by NHS-trained genomic experts.

AI & Machine LearningBiotechDigital Health

Co-investorsQVenturesFuture Planet Capital

Cytora is a risk digitization and automation platform for commercial insurance that uses AI to help brokers, insurers, and reinsurers receive, process, and make decisions on risk submissions.

AI & Machine LearningInsurTech

Co-investorsClaret Capital PartnersParkwalk Advisors

Deeptech Labs is a venture capital fund and accelerator that invests £100k–£350k in post-seed and seed-stage deeptech startups and runs a structured multi-week program ending in a Demo Day.

Deep TechCambridge, GB

Co-investorsEMV CapitalARM

Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform.

AI & Machine LearningBiotechHealthtechMontreal, CA

Claude PerreaultPierre Thibault

Co-investorsAdvent Life SciencesCTI Life Sciences Fund L.P.adMare BioInnovationsFonds de solidarité FTQ

Fluidic develops biophysics and single-cell analysis tools, including Fluidity One-M for in-solution protein interaction analysis using Microfluidic Diffusional Sizing and the Cyto-Mine platform for high-throughput single-cell screening via picodroplet microfluidics.

BiotechDeep TechHardware

James Wilkinsonin

Co-investorsHeran PartnersDraper Esprit

GENinCode develops genetic and clinical testing products for cardiovascular disease and familial hypercholesterolemia, providing risk assessment and prediction to help physicians stratify patients and select treatment pathways.

BiotechDigital HealthMedical DevicesOxford, GB

Co-investorsMaven Capital Partners

Co-investorsSofinnova Ventures

Imagen is a cloud-native media asset management platform that enables organizations to manage, enrich, and distribute large-scale video files.

Cloud ComputingEnterprise SoftwareMedia & Entertainment

Co-investorsGuinness VenturesCadenzaHaystackMenlo VenturesScript Capital

Co-investorsFuture Planet Capital

Microbiotica develops defined live biotherapeutic products based on microbiome science for immuno-oncology and inflammatory bowel disease treatment.

BiotechHealthtechMedical Devices

Co-investorsSeventure PartnersDCVC (Data Collective)

A biopharmaceutical company operating in early drug development, commercialization, and life cycle management within the therapeutics and life sciences industry.

Biotech

Thomas

Nuclera develops eProtein Discovery, a benchtop protein screening system that uses cell-free protein synthesis and digital microfluidics to design, screen, characterize, and express proteins in-house.

BiotechDeep TechHardware

Co-investorsAmadeus Capital PartnersFuture Planet Capital

Origami is an AI-powered platform that helps sales teams identify and enrich prospective customers through intelligent prospecting and signal-based lead generation.

AI & Machine LearningEnterprise SoftwareSaaSSales TechSan Francisco, US

Finn Mallery(Founder)inKenson Chung(Founder)in

Co-investorsY CombinatorOctopus Ventures

Novel antibody-based therapeutics platform for animal health.

Co-investorsCompanion FundDigitalis VenturesParkwalk Advisors

Pragmatic Semiconductor makes FlexICs, ultra-thin flexible integrated circuits built with thin-film transistor technology on flexible substrates for edge and item-level intelligence applications.

Deep TechHardwareSemiconductors

Co-investorsFuture Planet CapitalIn-Q-TelMaven Capital PartnersNorthern GritstoneProsperity7 VenturesMilltrust International Group

Riverlane builds quantum error correction hardware and software, including its Deltaflow real-time QEC system, for quantum computer makers.

Steve Brierley(Founder)in

Co-investorsAmadeus Capital PartnersETF PartnersMolten Ventures

Spin-out from the Universities of Oxford and Munster developing a novel semiconductor chip.

Vaysh Kewada(Founder)in

Co-investorsOxford Science EnterprisesPerivoli InnovationsSilicon Catalyst

Secondmind builds cloud-native software using its Active Learning machine learning technology to help automotive engineers design and optimize complex vehicle systems with less data, fewer simulations, and fewer prototypes.

AI & Machine LearningDeep TechSaaS

Gary Brotmanin

Co-investorsAmadeus Capital PartnersAtlantic Bridge VenturesReefknot Investments

Seldon provides a Kubernetes-native MLOps and LLMOps platform for deploying, scaling, and governing machine learning and AI models in production across any cloud or on-premise environment.

AI & Machine LearningCloud ComputingDeveloper ToolsLondon, GB

Co-investorsAlbionVCBright Pixel CapitalTechstarsAmadeus Capital PartnersPlayfair Capital

Seldon provides synthetic user personas built from real user analytics, ethnographic research, and Big Five (OCEAN) personality modeling to simulate user behavior and test product decisions before launch.

AI & Machine LearningEnterprise SoftwareSaaS

Co-investorsMaC Venture CapitalProtagonistAlbionVCAmadeus Capital Partners

Co-investorsCambridge Angels groupOctopus Ventures

Sortera engineers antibodies with complex properties using its Deep Screening platform, which pairs conditional KD-grade binding measurement with full-length sequence data across millions of variants.

AI & Machine LearningBiotechDeep Tech

STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.

BiotechHealthtechMedical Devices

Co-investorsFast Track InitiativeM VenturesPfizer Venture InvestmentsSeroba Life SciencesTaiho Ventures, LLCUTokyo Innovation Platform Co. Ltd.

T-Therapeutics develops bispecific TCR-CD3 T cell engagers built on its OpTiMus TCR discovery platform to target previously undruggable intracellular targets.

BiotechDeep TechHealthtechCambridge, GB

Co-investorsF-Prime CapitalSanofi VenturesSofinnova PartnersDigitalis Ventures

Platform company targeting selective clearance of intracellular protein aggregates in neurodegenerative disease.

Co-investorsM VenturesPfizer Venture InvestmentsStart Codon

UnlikelyAI builds AI technology designed to support real-world decision-making through interpretable and trustworthy models.

AI & Machine LearningEnterprise Software

Co-investorsAmadeus Capital PartnersCambridge Angels groupMetaplanetMS&AD VenturesOctopus Ventures

TrimTech Therapeutics develops a portfolio of targeted protein degraders, called TRIMTACs and TRIMGLUEs, that selectively remove toxic protein aggregates.

BiotechDeep Tech

Co-investorsPfizer Venture Investments

Co-investorsUniversity of Cambridge Enterprise